MatthewAllenWiklerMD

PubMed

• 15 citations
  Single intravenous dose of oritavancin for treatment of acute skin and skin structure infections caused by gram-positive bacteria: Summary of safety analysis from the ...
  G. R. Corey, Jeffery Loutit, Greg Moeck, M.W. Wikler, Michael N. Dudley, William O'Riordan> ;Antimicrobial Agents and Chemotherapy. 2018 Mar 27
• 26 citations
  Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large ...
  G. Ralph Corey, Francis F. Arhin, Matthew A. Wikler, Daniel F. Sahm, Barry N. Kreiswirth, José R. Mediavilla, Samantha Good, Claude Fiset, Hai Jiang, Greg Moeck, Heidi...> ;International Journal of Antimicrobial Agents. 2016 Nov 1
• 3 citations
  Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting.
  Daniel H Deck, Jennifer M Jordan, Thomas L Holland, Weihong Fan, Matthew A Wikler, Katherine A Sulham, G Ralph Corey> ;Infectious Diseases and Therapy. 2016 Sep 1
• 4 citations
  Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting.
  Daniel H Deck, Jennifer M Jordan, Thomas L Holland, Weihong Fan, Matthew A Wikler, Katherine A Sulham, G Ralph Corey> ;Infectious Diseases and Therapy. 2016 Sep 1
• 162 citations
  Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority...
  G. Ralph Corey, Samantha Good, Hai Jiang, Greg Moeck, Matthew A. Wikler, Sinikka Green, Paul Manos, Richard Keech, Rajesh P Singh, Barry Heller, Natalia Bubnova, Willi...> ;Clinical Infectious Diseases. 2015 Jan 15
• 14 citations
  Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains.
  Ronald N. Jones, Douglas J. Biedenbach, Paul G. Ambrose, Matthew A. Wikler> ;Diagnostic Microbiology and Infectious Disease. 2008 Sep 1
• 5 citations
  Correction of a Reference to Clinical Laboratory Standards Institute Interpretive Criteria
  Matthew A. Wikler, Mary Jane Ferraro> ;Clinical Infectious Diseases. 2008 Jun 1
• 6 citations
  Comparing Gatifloxacin and Clarithromycin in Pneumonia Symptom Resolution and Process of Care
  Nathan C. Dean, Paul Sperry, Matthew A. Wikler, Mary S. Suchyta, Carol J Hadlock> ;Antimicrobial Agents and Chemotherapy. 2006 Apr 1
• 96 citations
  Use of Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Phase 2 and 3 Dosing Strategies for Doripenem
  Sujata M. Bhavnani, Jeffrey P. Hammel, Brenda Cirincione, Matthew A. Wikler, Paul G. Ambrose> ;Antimicrobial Agents and Chemotherapy. 2005 Sep 1
• 39 citations
  In Vitro Activity of Doripenem (S-4661) against Multidrug-Resistant Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis
  Yunhua Chen, Elizabeth Garber, Qiuqu Zhao, Yigong Ge, Matthew A. Wikler, Koné Kaniga, Lisa Saiman> ;Antimicrobial Agents and Chemotherapy. 2005 Jun 1
• 70 citations
  In Vitro Antimicrobial Activity of Doripenem, a New Carbapenem
  Yigong Ge, Matthew A. Wikler, Daniel F. Sahm, Renée S. Blosser-Middleton, James A. Karlowsky> ;Antimicrobial Agents and Chemotherapy. 2004 Apr 1
• 7 citations
  Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin.
  Lawrence David Sher, Michael D. Poole, Kristen Von Seggern, Matthew A. Wikler, Susan C. Nicholson, George A. Pankey> ;Otolaryngology--Head and Neck Surgery. 2002 Sep 1
• 11 citations
  Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study
  Mark H. Gotfried, Thomas C. Quinn, Samantha Gothelf, Matthew A. Wikler, C.Douglas Webb, Susan C. Nicholson> ;Diagnostic Microbiology and Infectious Disease. 2002 Sep 1
• 11 citations
  Efficacy and tolerability of gatifloxacin in community treatment of acute exacerbations of chronic bronchitis.
  Antonio Anzueto, Mark H. Gotfried, Matthew A. Wikler, Rene Russo, Susan C. Nicholson> ;Clinical Therapeutics. 2002 Jun 1
• Five cephalosporins: pharmacokinetics and their relation to antibacterial potency.
  Sohn, C., Pitkin, D., Grappel, S., Zajac, I., Actor, P., Alexander, F., Lentnek, A., Wikler, M., Stote, R., Dubb, J.> ;Clin Ther. 1984
• Efficacy of ceftizoxime administered twice daily in hospitalized patients with respiratory tract infections.
  Lentnek, A., Wikler, M., McDevitt, J., Sohn, C.> ;Clin Ther. 1984
• Comparison of ceftizoxime versus combination therapy in the treatment of pelvic inflammatory disease (PID).
  Wikler, M. A., Moonsammy, G. I., Hemsell, D. L.> ;J Chemother. 1989 Jul
• Lack of correlation between in vitro susceptibility data of anaerobes to ceftizoxime and clinical response.
  Wikler, M. A., Moonsammy, G. I., Nichols, R. L.> ;J Chemother. 1989 Jul
• Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
  Lentnek, A. L., Evrard, H. M., Wikler, M. A., Sohn, C. A., Phillips, S. W.> ;Clin Ther. 1985 Jan 01
• Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
  Nichols, R. L., Wikler, M. A., McDevitt, J. T., Lentnek, A. L., Hosutt, J. A.> ;Antimicrob Agents Chemother. 1987 Feb
• Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery.
  Platt, R., Zaleznik, D. F., Hopkins, C. C., Dellinger, E. P., Karchmer, A. W., Bryan, C. S., Burke, J. F., Wikler, M. A., Marino, S. K., Holbrook, K. F.> ;N Engl J Med. 1990 Jan 18
• Interchangeability of ceftizoxime and cefoxitin: a clinical perspective.
  Wikler, M. A.> ;Clin Ther. 1990
• Prophylaxis against wound infection following herniorrhaphy or breast surgery.
  Platt, R., Zucker, J. R., Zaleznik, D. F., Hopkins, C. C., Dellinger, E. P., Karchmer, A. W., Bryan, C. S., Burke, J. F., Wikler, M. A., Marino, S. K.> ;J Infect Dis. 1992 Sep
• Perioperative antibiotic prophylaxis and wound infection following breast surgery.
  Platt, R., Zucker, J. R., Zaleznik, D. F., Hopkins, C. C., Dellinger, E. P., Karchmer, A. W., Bryan, C. S., Burke, J. F., Wikler, M. A., Marino, S. K.> ;J Antimicrob Chemother. 1993 Feb
• Join now to see all